Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umansky

Showing results (351-360 of 549) with videos related to

Pageof 55
Sort By:
Physical Review Letters|April 20, 2004
Demonstration of a 1/4-cycle phase shift in the radiation-induced oscillatory magnetoresistance in GaAs/AlGaAs devicesR G Mani, J H Smet, K von Klitzing, et al.
Cell Reports|November 23, 2017
CCR5 Directs the Mobilization of CD11b<sup>+</sup>Gr1<sup>+</sup>Ly6C<sup>low</sup> Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor DevelopmentElias Hawila, Hila Razon, Gizi Wildbaum, et al.
Nature Communications|December 23, 2017
Transmission of heat modes across a potential barrierAmir Rosenblatt, Fabien Lafont, Ivan Levkivskyi, et al.
Frontiers in Immunology|March 20, 2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced ImmunosuppressionViktor Fleming, Xiaoying Hu, Rebekka Weber, et al.
Pediatrics|April 30, 2026
Integrating Social and Emotional Care Across the First Thousand Days in Safety-Net Health CareYonit Lax, Annika Brauer, Jamie Canton, et al.
Frontiers in Immunology|June 10, 2024
Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysisMaximilian Möller, Vanessa Orth, Viktor Umansky, et al.
Physical Review Letters|March 10, 2012
NMR probing of the spin polarization of the ν=5/2 quantum Hall stateM Stern, B A Piot, Y Vardi, et al.
Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.
International Journal of Cancer|December 13, 2012
Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancerIvan Shevchenko, Svetlana Karakhanova, Sabine Soltek, et al.
Drug and Chemical Toxicology|July 17, 2001
Apoptosis induction and cell cycle perturbation in established cell lines by peroxysomicine A1 (T-514)F J Martinez, G Q Zeng, A Piñeyro, et al.
Pageof 55

Showing results (351-360 of 549) with videos related to

Sort By:
Pageof 55
Physical Review Letters|April 20, 2004
Demonstration of a 1/4-cycle phase shift in the radiation-induced oscillatory magnetoresistance in GaAs/AlGaAs devicesR G Mani, J H Smet, K von Klitzing, et al.
Cell Reports|November 23, 2017
CCR5 Directs the Mobilization of CD11b<sup>+</sup>Gr1<sup>+</sup>Ly6C<sup>low</sup> Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor DevelopmentElias Hawila, Hila Razon, Gizi Wildbaum, et al.
Nature Communications|December 23, 2017
Transmission of heat modes across a potential barrierAmir Rosenblatt, Fabien Lafont, Ivan Levkivskyi, et al.
Frontiers in Immunology|March 20, 2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced ImmunosuppressionViktor Fleming, Xiaoying Hu, Rebekka Weber, et al.
Pediatrics|April 30, 2026
Integrating Social and Emotional Care Across the First Thousand Days in Safety-Net Health CareYonit Lax, Annika Brauer, Jamie Canton, et al.
Frontiers in Immunology|June 10, 2024
Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysisMaximilian Möller, Vanessa Orth, Viktor Umansky, et al.
Physical Review Letters|March 10, 2012
NMR probing of the spin polarization of the ν=5/2 quantum Hall stateM Stern, B A Piot, Y Vardi, et al.
Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.
International Journal of Cancer|December 13, 2012
Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancerIvan Shevchenko, Svetlana Karakhanova, Sabine Soltek, et al.
Drug and Chemical Toxicology|July 17, 2001
Apoptosis induction and cell cycle perturbation in established cell lines by peroxysomicine A1 (T-514)F J Martinez, G Q Zeng, A Piñeyro, et al.
Pageof 55